Clinical Trial Update: Reducing Donor Specific Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients (DSA Study) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating strategies to reduce donor-specific antibody strength in maintenance kidney transplant recipients; results were posted in 2014…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Kidney Failure
• Kidney Transplantation

Snippet

Sponsor: East Carolina University | Conditions: Transplant; Failure, Kidney | Phase 4 | Status: COMPLETED | Results posted: 2014-10-20